A HECT Ubiquitin-protein Ligase As a Novel Candidate Gene for Altered Quinine and Quinidine Responses in Plasmodium Falciparum

Overview

Journal PLoS Genet

Specialty Genetics

Date 2014 May 17

PMID 24830312

Citations 22

Authors

Cecilia P Sanchez

Chia-Hao Liu

Sybille Mayer

Astutiati Nurhasanah

Marek Cyrklaff

Jianbing Mu

Michael T Ferdig

Wilfred D Stein

Michael Lanzer

Affiliations

Soon will be listed here.

Abstract

The emerging resistance to quinine jeopardizes the efficacy of a drug that has been used in the treatment of malaria for several centuries. To identify factors contributing to differential quinine responses in the human malaria parasite Plasmodium falciparum, we have conducted comparative quantitative trait locus analyses on the susceptibility to quinine and also its stereoisomer quinidine, and on the initial and steady-state intracellular drug accumulation levels in the F1 progeny of a genetic cross. These data, together with genetic screens of field isolates and laboratory strains associated differential quinine and quinidine responses with mutated pfcrt, a segment on chromosome 13, and a novel candidate gene, termed MAL7P1.19 (encoding a HECT ubiquitin ligase). Despite a strong likelihood of association, episomal transfections demonstrated a role for the HECT ubiquitin-protein ligase in quinine and quinidine sensitivity in only a subset of genetic backgrounds, and here the changes in IC50 values were moderate (approximately 2-fold). These data show that quinine responsiveness is a complex genetic trait with multiple alleles playing a role and that more experiments are needed to unravel the role of the contributing factors.

Citing Articles

Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II genetic cross.

Kanai M, Mok S, Yeo T, Shears M, Ross L, Jeon J bioRxiv. 2024; .

PMID: 39386571 PMC: 11463348. DOI: 10.1101/2024.09.27.615529.

Plasmodium falciparum contains functional SCF and CRL4 ubiquitin E3 ligases, and CRL4 is critical for cell division and membrane integrity.

Rizvi Z, Reddy G, Gorde S, Pundir P, Das D, Sijwali P PLoS Pathog. 2024; 20(2):e1012045.

PMID: 38416790 PMC: 10927090. DOI: 10.1371/journal.ppat.1012045.

Deaggregation of mutant Plasmodium yoelii de-ubiquitinase UBP1 alters MDR1 localization to confer multidrug resistance.

Xu R, Lin L, Jiao Z, Liang R, Guo Y, Zhang Y Nat Commun. 2024; 15(1):1774.

PMID: 38413566 PMC: 10899652. DOI: 10.1038/s41467-024-46006-3.

pH-dependence of the Plasmodium falciparum chloroquine resistance transporter is linked to the transport cycle.

Berger F, Gomez G, Sanchez C, Posch B, Planelles G, Sohraby F Nat Commun. 2023; 14(1):4234.

PMID: 37454114 PMC: 10349806. DOI: 10.1038/s41467-023-39969-2.

Antimalarial Drug Resistance: A Brief History of Its Spread in Indonesia.

Fitri L, Pawestri A, Winaris N, Endharti A, Khotimah A, Abidah H Drug Des Devel Ther. 2023; 17:1995-2010.

PMID: 37431492 PMC: 10329833. DOI: 10.2147/DDDT.S403672.

References

Hunt P, Afonso A, Creasey A, Culleton R, Sidhu A, Logan J . Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. Mol Microbiol. 2007; 65(1):27-40. PMC: 1974797. DOI: 10.1111/j.1365-2958.2007.05753.x. View

Sidhu A, Verdier-Pinard D, Fidock D . Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science. 2002; 298(5591):210-3. PMC: 2954758. DOI: 10.1126/science.1074045. View

Zhang Y, Qu X, Hu X, Yang X, Hou K, Teng Y . Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells. J Pathol. 2009; 218(2):248-55. DOI: 10.1002/path.2533. View

Price R, Uhlemann A, Brockman A, McGready R, Ashley E, Phaipun L . Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004; 364(9432):438-447. PMC: 4337987. DOI: 10.1016/S0140-6736(04)16767-6. View

Tyner S, Lon C, Se Y, Bethell D, Socheat D, Noedl H . Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay. Malar J. 2012; 11:198. PMC: 3403988. DOI: 10.1186/1475-2875-11-198. View

Bennett T, Patel J, Ferdig M, Roepe P . Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance. Mol Biochem Parasitol. 2007; 153(1):48-58. PMC: 2747254. DOI: 10.1016/j.molbiopara.2007.01.018. View

Mu J, Ferdig M, Feng X, Joy D, Duan J, Furuya T . Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol. 2003; 49(4):977-89. DOI: 10.1046/j.1365-2958.2003.03627.x. View

Briolant S, Pelleau S, Bogreau H, Hovette P, Zettor A, Castello J . In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo. Malar J. 2011; 10:37. PMC: 3055222. DOI: 10.1186/1475-2875-10-37. View

Ingmundson A, Nahar C, Brinkmann V, Lehmann M, Matuschewski K . The exported Plasmodium berghei protein IBIS1 delineates membranous structures in infected red blood cells. Mol Microbiol. 2012; 83(6):1229-43. PMC: 3502748. DOI: 10.1111/j.1365-2958.2012.08004.x. View

10.

Chung D, Ponts N, Prudhomme J, Rodrigues E, Le Roch K . Characterization of the ubiquitylating components of the human malaria parasite's protein degradation pathway. PLoS One. 2012; 7(8):e43477. PMC: 3422240. DOI: 10.1371/journal.pone.0043477. View

11.

Cooper R, Ferdig M, Su X, Ursos L, Mu J, Nomura T . Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol. 2001; 61(1):35-42. DOI: 10.1124/mol.61.1.35. View

12.

Park D, Lukens A, Neafsey D, Schaffner S, Chang H, Valim C . Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite. Proc Natl Acad Sci U S A. 2012; 109(32):13052-7. PMC: 3420184. DOI: 10.1073/pnas.1210585109. View

13.

Saridaki T, Sanchez C, Pfahler J, Lanzer M . A conditional export system provides new insights into protein export in Plasmodium falciparum-infected erythrocytes. Cell Microbiol. 2008; 10(12):2483-95. DOI: 10.1111/j.1462-5822.2008.01223.x. View

14.

Waller K, Muhle R, Ursos L, Horrocks P, Verdier-Pinard D, Sidhu A . Chloroquine resistance modulated in vitro by expression levels of the Plasmodium falciparum chloroquine resistance transporter. J Biol Chem. 2003; 278(35):33593-601. DOI: 10.1074/jbc.M302215200. View

15.

Nkrumah L, Riegelhaupt P, Moura P, Johnson D, Patel J, Hayton K . Probing the multifactorial basis of Plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol Biochem Parasitol. 2009; 165(2):122-31. PMC: 3082771. DOI: 10.1016/j.molbiopara.2009.01.011. View

16.

Kuhn Y, Sanchez C, Ayoub D, Saridaki T, Van Dorsselaer A, Lanzer M . Trafficking of the phosphoprotein PfCRT to the digestive vacuolar membrane in Plasmodium falciparum. Traffic. 2009; 11(2):236-49. DOI: 10.1111/j.1600-0854.2009.01018.x. View

17.

Jiang H, Yi M, Mu J, Zhang L, Ivens A, Klimczak L . Detection of genome-wide polymorphisms in the AT-rich Plasmodium falciparum genome using a high-density microarray. BMC Genomics. 2008; 9:398. PMC: 2543026. DOI: 10.1186/1471-2164-9-398. View

18.

Huttinger F, Satimai W, Wernsdorfer G, Wiedermann U, Congpuong K, Wernsdorfer W . Sensitivity to artemisinin, mefloquine and quinine of Plasmodium falciparum in northwestern Thailand. Wien Klin Wochenschr. 2010; 122 Suppl 3:52-6. DOI: 10.1007/s00508-010-1438-6. View

19.

Fidock D, Nomura T, Talley A, Cooper R, Dzekunov S, Ferdig M . Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000; 6(4):861-71. PMC: 2944663. DOI: 10.1016/s1097-2765(05)00077-8. View

20.

Yuan J, Cheng K, Johnson R, Huang R, Pattaradilokrat S, Liu A . Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. Science. 2011; 333(6043):724-9. PMC: 3396183. DOI: 10.1126/science.1205216. View